Ratings EMS-CHEMIE HOLDING AG London S.E.

Equities

0QM9

CH0016440353

Market Closed - London S.E. Other stock markets 11:20:00 2024-07-05 am EDT			5-day change	1st Jan Change
761.5 ^CHF	+2.21%		+3.39%	+11.82%

Jun. 25	Mirabaud Securities Lifts Price Target on EMS-Chemie Holding AG, Maintains Hold Recommendation	MT
May. 09	Berenberg Lifts Price Target on EMS-Chemie, Maintains Hold Recommendation	MT

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
With an expected P/E ratio at 38.69 and 34.62 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Based on current prices, the company has particularly high valuation levels.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The valuation of the company is particularly high given the cash flows generated by its activity.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
EMS-CHEMIE HOLDING AG	+11.82%	19.86B	-
ECOLAB INC.	+20.09%	68.02B	A-
SIKA AG	-5.30%	46.34B	A-
GIVAUDAN SA	+22.19%	43.77B	B+
FUJIFILM HOLDINGS CORPORATION	+36.70%	28.93B	A-
SYMRISE AG	+14.26%	17.23B	B+
POSCO FUTURE M CO., LTD.	-25.77%	14.95B	A-
CELANESE CORPORATION	-14.93%	14.44B	B+
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-31.27%	11.82B	A-
ALBEMARLE CORPORATION	-31.93%	11.56B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes